See also stories tagged with Biological Engineering
Designing an effective antibody drug is like searching for the right key in a warehouse of locks. Scientists may begin with millions—or even billions—of antibody candidates, but only a tiny fraction will recognize and bind ...
More than 100,000 people are awaiting an organ transplant in the United States, with a new candidate added to the list every 10 minutes. Even if the transplant is carried out successfully, recipients must take immunosuppressive ...
The decades-old scientific quest to create brand-new proteins has been turbocharged in the era of artificial intelligence.
In 1968, the American biochemist and geneticist Marshall Nirenberg and his colleagues won the Nobel Prize in physiology or medicine for their work deciphering how an organism's proteins are directly linked to its genetic ...
Engineers have developed a strain of a common bacterial species that can feed exclusively on the three major sugars present in corn stalks. While the new multiple-sugar-consuming strain of the bacterium Pseudomonas putida ...
Rice University engineers have developed a new strategy for controlling how therapeutic peptides are released from gelatin-based materials, a step that could make the small but powerful molecules more useful in tissue engineering ...
A protein known as interleukin 10 (IL-10) is the lynchpin of a new method to protect transplanted cells from host immune system attacks. Rice University researchers engineered a living factory to produce a localized biochemical ...
For decades, scientists have accepted that the immune system naturally weakens with age. Georgia Tech biomedical engineer and Carl Ring Family Professor Ankur Singh wasn't convinced. Then the COVID-19 pandemic made the stakes ...
How do tissues cope with being stretched for hours or even days? A study led by researchers at the Institute for Bioengineering of Catalonia (IBEC) has uncovered an unexpected answer: Cells radically reorganize their internal ...
Oral squamous cell carcinoma (OSCC) is the most common form of head and neck cancer, and the number of new cases is predicted to rise by 30% in the next decade. Despite decades of cancer research, treating OSCC remains a ...
